Comphensive Guide to Accessory Nutrients and Essential Oils by Dr. James Meschino - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

3. Other Considerations

As Melatonin is also an antioxidant, an immune system modulator and a core temperature regulator it is being

tested for various other health applications:

www.meschinohealth.com

index-65_1.png

index-65_2.png

65

Meschino Health Comprehensive Guide to Accessory Nutrients and Essential Oils

Accessory Nutrients and Essential Oils

a. Tension and cluster headaches - Some preliminary, double-blind studies suggest that Melatonin supplementation

may help in certain cases (1-3 mg at night).17,18 This af ect has been at ributed to Melatonin’s ability to prevent a

rise in core temperature, which is linked to cluster headaches.35,36

b. Sarcoidosis - Preliminary evidence has shown improvement in patients with sarcoidosis (20 mg at night).19

c. Adjunctive Cancer Treatment - Early trials indicate that Melatonin supplementation, as an adjunct to cancer

treatment may help inhibit the progression of breast cancer, reduce the PSA levels in prostate cancer patients and

improve disease-free survival in melanoma patients, as well as patients with brain and lung cancer (20 mg at night).

Of course, more research is required before any conclusive statements can be made about this application.20-27 In

a study of cancer patients with solid tumors in various organs the intake of Melatonin (40 mg per day) enhanced the

ef ectiveness of interleukin-2 therapy by enhancing its anti-tumor immune ef ect or by increasing susceptibility of

cancer cells to the cytolysis by cytotoxic lymphocytes.37

d. Immune System and AIDS - Maestroni and Conti demonstrated in 1995 that T-helper-2 lymphocytes possess

Melatonin receptors. When Melatonin docks with its receptor on the T-helper cell, a cascade of events is set in

motion releasing important signalling agents (cytokines) that strengthen immune function in various ways. For

example, natural killer cell production rose by 240 percent in healthy young men taking 20 mg of Melatonin each

night for a period of two months.

Melatonin may also inhibit viral replication and has been shown to increase T-helper cell numbers and natural killer

cell numbers in HIV-infected individuals. Further research is underway to substantiate these findings (20 mg at

night).28,29

e. Birth Control/Contraceptive - Very high doses of Melatonin inhibits ovulation in animals and women. A new birth

control is now being tested known as B-Oval. It contains no estrogen, but rather high dose Melatonin (75 mg) and

0.3 mg of progestin.30

Dosage Ranges

Insomnia and Jet Lag (Shift Workers) - 0.1 mg to 3.0 mg (note 0.1 mg equals 100 mcg), one to two hours before

bedtime. It is best to start with a small dose and work up, based upon improved sleep with no awakening and morning

drowsiness.

N.B. Taking a high dosage of Melatonin (5 – 75 mg) should only be undertaken with knowledge of a physician, who is

able to monitor blood work and other parameters, as these dosages are still experimental and long-term safety is

unknown at this time.38

Adverse Side Effects and Toxicity

Taking doses that are too high can result in morning grogginess, headaches and/or abdominal cramps.31,32

Melatonin testing in humans and animals indicate that it is very non-toxic.1,33

www.meschinohealth.com

index-66_1.png

index-66_2.png

66

Meschino Health Comprehensive Guide to Accessory Nutrients and Essential Oils

Accessory Nutrients and Essential Oils

Contraindications and Drug-Nutrient Interactions

Some cases of depression can be aggravated by Melatonin supplementation.34 Some antidepressant drugs stimulate

the production of Melatonin and others, such as fluoxetine (Prozac), may lower Melatonin levels. It is probably best at

this time not to combine Melatonin with any other drug that targets brain chemistry or neurotransmitter levels.35,36

A number of drugs have been shown to deplete Melatonin levels. Some of these include aspirin, ibuprofen, beta-

blockers, calcium channel blockers, sleeping pills, tranquillizers, fluoxetine (Prozac), caffeine, steroids and tobacco.1

The clinical significance of this is yet to be determined, in regards to whether or not patients on these substances

require Melatonin supplementation to compensate for the depletion of Melatonin (author’s note).

1. Reitar RJ, Robinson J. Melatonin. New York, NY: Bantam Books; 1995. p. 3-30.

2. Shida CS, Castrucci AML, Lamy-Freund MT. High melatonin solubility in aqueous medium. J Pineall Res 1994;16:198-201.

3. Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacol

1990;100:222-6.

4. Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ. Sleep-inducing effects of low doses of melatonin ingested in the

evening. Clin Pharmacol Ther 1995;57:552-8.

5. Dahlitz M, Alverez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet

1991;337:1121-4.

6. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. The effects of exogenous melatonin on the total sleep time and day-time

alertness of chronic insomniacs: A preliminary study. Biol Psychiatry 1991;30:371-6.

7. James SP, et al. Melatonin administration in insomnia. Neuropsychopharmacology 1990;3:19-23.

Comment [c32]: Could not find other authors

8. Nave R, Peled R, Lavie P. Melatonin improves evening napping. Eur J Pharmacol 1995;275:213-6.

9. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, et al. Sleep disorders and melatonin rhythms elderly people. BMJ

1994;309:167.

10. Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep maintenance insomnia: assessment in a

clinical trial of melatonin replacement. Sleep 1998;21:52-68.

11. Arendt J, Aldhous M, English J, Marks V, Arendt JH, Marks M, et al. Some effects of jet-lag and their alleviation by melatonin.

Ergonomics 1987;30:1379-98.

12. Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: Confirmatory result using a simplified protocol. Biol

Psychiatry 1992;32:705-11.

13. Petrie K, Conaglen JV, Thompson L, Chamberlain K. Effect of melatonin on jet lag after long haul flights. Br Med J 1989;298:705-7.

14. Lino A, Silvy S, Condorelli L, Rusconi AC. Melatonin and jet lag: Treatment schedule. Biol Psychiatry 1993;34:587.

15. Petrie K, Dawson AG, Thompson L, Brook R. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol

Psychiatry 1993;33:526-30.

16. Folkard S, Arendt J, Clark M. Can melatonin improve shift workers’ tolerance of the night shift: Some preliminary findings. Chronobio

Intern 1993;10,5:315-20.

17. Nagtegaal JE, Smits MG, Swart AC, Kerkhof GA, van der Meer YG. Melatonin-responsive headache in delayed sleep phase syndrome:

Preliminary observations. Headache 1998;38:303-7.

18. Leone M, D’Amico D, Moschiano F, et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with

parallel groups. Cephalagia 1996;16:494-6.

19. Cagnoni ML, Lombardi A, Cerinic MC, Dedola GL, Pignone A. Melatonin for treatment of chronic refractory sarcoidosis [letter]. Lancet

1995;346(4):1229-30.

20. Lissoni P, et al. A randomized study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone

Comment [c33]: Could not find the other authors

melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994;69:196-9.

21. Lissoni P, Barni S, Fossati V, Ardizzoia A, Cazzaniga M, Tancini G, et al. A randomized study of neuroimmunotherapy with low-dose

subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable matastatic solid tumor. Support

Care Cancer 1995;3(3):194-7.

www.meschinohealth.com

index-67_1.png

index-67_2.png

67

Meschino Health Comprehensive Guide to Accessory Nutrients and Essential Oils

Accessory Nutrients and Essential Oils

22. Neri B, Fiorelli C, Moroni F, Nicita G, Paoletti MC, Ponchieatti R, et al. Modulation of human lymphoblastoid interferon activity by

melatonin in metastatic renal cell carcinoma: A phase II study. Cancer 1994;73(12):3014-9.

23. Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, et al. Modulation of cancer endocrine therapy by melatonin: A phase

II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995;71(4):854-